JFG has served on the scientific advisory boards for Eli Lilly & Co. and GlaxoSmithKline; and has served on a speakers bureau for Abbott, AstraZeneca, Eli Lilly & Co., GlaxoSmithKline and Pfizer.
The modern pharmacopoeia: a return to depressive realism?
Article first published online: 18 NOV 2008
© 2008 The Author. Journal compilation © 2008 Blackwell Munksgaard
Volume 10, Issue 8, pages 969–972, December 2008
How to Cite
Goldberg, J. F. (2008), The modern pharmacopoeia: a return to depressive realism?. Bipolar Disorders, 10: 969–972. doi: 10.1111/j.1399-5618.2008.00632.x
- Issue published online: 18 NOV 2008
- Article first published online: 18 NOV 2008